2019
DOI: 10.4103/japtr.japtr_26_19
|View full text |Cite
|
Sign up to set email alerts
|

Advances in orally targeted drug delivery to colon

Abstract: Colon-specific drug delivery is critical for treating diseases of colon, such as colon cancer, amoebiasis, irritable bowel syndrome, and inflammatory bowel disease. This study reviews the effects of targeted oral drug delivery on patient by measuring the accurate administration of the drug to specific disease spot, thus enhancing the therapeutic efficacy and provides better therapeutic outcomes. Medically targeted delivery to colon produces local effect on the diseases and hinders the systemic toxic effects of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(5 citation statements)
references
References 48 publications
0
5
0
Order By: Relevance
“…The size of the polymer also affects this behaviour, as it affects the surface area available for fluid penetration. The ability to control this behaviour encourages the use of polymers in many pharmaceutical drug delivery systems [1][2][3][4][5][6][7]. The pellets' swelling was examined in phosphate-buffered saline (PBS).…”
Section: Pellets' Swelling Assessmentmentioning
confidence: 99%
See 1 more Smart Citation
“…The size of the polymer also affects this behaviour, as it affects the surface area available for fluid penetration. The ability to control this behaviour encourages the use of polymers in many pharmaceutical drug delivery systems [1][2][3][4][5][6][7]. The pellets' swelling was examined in phosphate-buffered saline (PBS).…”
Section: Pellets' Swelling Assessmentmentioning
confidence: 99%
“…Targeted drug delivery to the colon has attracted the attention of many researchers owing to its tremendous advantages over systemic drug administration, including increased drug potency and efficacy and reduced adverse drug reactions [1,2]. Colonic drug delivery systems have been used to treat a plethora of bowel diseases encompassing colorectal carcinoma, ulcerative colitis, diverticulitis, Crohn's disease, and irritable bowel syndrome [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…Some materials are resistant to gastric digestion (e.g., cellulose and cellulose derivates, resistant starch, some pectins and alginates, etc.) and serve for release of active compounds in the colon, being exposed to subsequent microbial degradation (Belali et al, 2019). Many reports stressed that gut microbial transformation could potentially improve the therapeutic effects of plant bioactive products, including EOs and particular terpenoids (Wang et al, 2019).…”
Section: Carriers Disintegration Under Gastric Conditionsmentioning
confidence: 99%
“…Mucoadhesion permits localized drug delivery, enabled by the high intestinal permeability of nanoparticles, which accumulate in specific intestinal sections. This strategy enhances drug bioavailability, reduces systemic toxicity, and increases patient compliance [21][22][23].…”
Section: Introductionmentioning
confidence: 99%